1. Home
  2. SW vs VTRS Comparison

SW vs VTRS Comparison

Compare SW & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smurfit WestRock plc Ordinary Shares

SW

Smurfit WestRock plc Ordinary Shares

HOLD

Current Price

$39.70

Market Cap

20.9B

Sector

N/A

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$15.55

Market Cap

17.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SW
VTRS
Founded
1934
1961
Country
Ireland
United States
Employees
97000
30000
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9B
17.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SW
VTRS
Price
$39.70
$15.55
Analyst Decision
Strong Buy
Buy
Analyst Count
12
4
Target Price
$53.58
$13.50
AVG Volume (30 Days)
4.6M
8.5M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
4.56%
3.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,299,900,000.00
Revenue This Year
$4.43
$4.41
Revenue Next Year
$3.13
$1.96
P/E Ratio
$38.98
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.73
$8.19
52 Week High
$52.65
$16.47

Technical Indicators

Market Signals
Indicator
SW
VTRS
Relative Strength Index (RSI) 47.08 71.30
Support Level $36.00 $12.90
Resistance Level $44.20 $16.38
Average True Range (ATR) 1.47 0.45
MACD -0.17 0.10
Stochastic Oscillator 44.35 91.69

Price Performance

Historical Comparison
SW
VTRS

About SW Smurfit WestRock plc Ordinary Shares

Smurfit WestRock PLC manufactures corrugated packaging and consumer packaging, such as folding cartons and paperboard. operates a vertically integrated system supplying wood and recovered fiber to produce various grades of board, which are then converted into packaging products. Its main packaging categories include corrugated containers and consumer packaging, with additional products such as solidboard, kraft paper, graphic board, paper sacks, and bag-in-box packaging. The company's geographical segments include North America (including the U.S., Canada and Mexico), Europe, the Middle East and Africa and Asia-Pacific, and Latin America. The majority of the company's revenue is derived from product sales in the North American region.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: